Assessment and Molecular Docking of SARS-CoV-۲ NSP۳ and NSP۱۲ Mutants in Iranian Patients in Golestan Province

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 152

This Paper With 11 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_INJPM-10-7_012

تاریخ نمایه سازی: 2 مرداد 1401

Abstract:

Background: Molecular analysis of SARS-CoV-۲ genome is important to predict viral pathogenicity. In addition to transmission, replication is a key factor in pathogenicity of the virus. Notably, mutations in non-structural proteins (NSP۳ and NSP۱۲) can affect host immune response and viral replication. Therefore, this study was conducted to investigate different mutations of SARS-CoV-۲ NSP۳, and NSP۱۲ during different waves of COVID-۱۹ infection.Methods: We recruited ۵۷ NGS sequences including ۸ NGS sequences from Golestan SARS-CoV-۲ RNA samples, obtained as part of clinical testing in different referral centers of Iran. After obtaining sequences from the global initiative on sharing all influenza data (GISAID), and evaluating and processing data, all sequences were aligned to the Wuhan variant genome (NC_۰۴۵۵۱۲.۲) using MEGA۶. The HDOCK server was used for molecular docking.Results: In NSP۳, mutations in positions (nts ۳۱۵, ۵۴۵, ۲۶۶۶, ۳۲۶۴) were more frequent and among them mutation in positions including nt ۵۴۵ (aa۱۸۲) and nt ۲۶۶۶ (aa۸۸۹) were associated with an increase in codon usage. In the term of NSP۱۲, mutations in positions such as nts ۴۰۶ (aa۱۳۷), ۹۶۵ (aa۳۲۳), ۱۲۳۳, ۱۶۵۳, ۱۸۳۶, ۲۷۳۳ were more frequent. The molecular docking results showed more affinity in some variants of NSP۳ and NSP۱۲ as well.Conclusion: This study has assessed mutation in SARS-CoV-۲ Nsp۳, and NSP۱۲ which are viral protease, and viral polymerase (RdRp). The mutations reported in this study may help this virus to replicate faster and evade the pharmaceutical agents which target viral polymerase activity and be very effective in viral pathogenesis. In addition, this study highlights the importance of ongoing genomic variation studies to be performed on SARS-CoV-۲ variants.

Authors

Emad Behboudi

Department of Microbiology, Golestan University of Medical Sciences. Gorgan, Iran.

Alijan Tabarraei

Department of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran

Alireza Tahamtan

Department of Microbiology, Golestan University of Medical Sciences. Gorgan, Iran.

Mohammad Reza Kalani

Senior Scientist, Enterprise-TTM, University of Pittsburgh Medical Center, Pittsburgh, PA

Abdolvahab Moradi

Dept. Microbiology. Faculty of Medicine, Golestan University of Medical Sciences

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Behboudi E, Shamsi A, Hamidi-Sofiani V, Oladnabi M. The effects ...
  • Behboudi E, Hamidi V, Gholizadeh F, Grala EM, Ghelmani Y, ...
  • Behboudi E, Hamidi-Sofiani V. New mutations causing the ۲۰۱۹ novel ...
  • Behboudi E, Hamidi-Sofiani V, Zeynali P. Review of Therapeutic Candidates ...
  • Ruan Z, Liu C, Guo Y, He Z, Huang X, ...
  • Shannon A, Le NT-T, Selisko B, Eydoux C, Alvarez K, ...
  • Khailany RA, Safdar M, Ozaslan M. Genomic characterization of a ...
  • Esmail S, Danter WR. Lung organoid simulations for modeling and ...
  • Lundstrom K, Seyran M, Pizzol D, Adadi P, Mohamed Abd ...
  • Ayatollahi AA, Aghcheli B, Amini A, Nikbakht H, Ghassemzadehpirsala P, ...
  • Erol A. Are the emerging SARS-COV-۲ mutations friend or foe? ...
  • Zandi M, Behboudi E, Soltani S. Role of glycoprotein hemagglutinin-esterase ...
  • Yadav R, Chaudhary JK, Jain N, Chaudhary PK, Khanra S, ...
  • Raj R. Analysis of non-structural proteins, NSPs of SARS-CoV-۲ as ...
  • Behboudi E, Hamidi-Sofiani V. CD۱۴۷: A missing key in the ...
  • Mirza MU, Froeyen M. Structural elucidation of SARS-CoV-۲ vital proteins: ...
  • McCallum M, Walls AC, Sprouse KR, Bowen JE, Rosen LE, ...
  • Huang J, Song W, Huang H, Sun Q. Pharmacological therapeutics ...
  • Zeng L, Li D, Tong W, Shi T, Ning B. ...
  • Wu R, Wang L, Kuo H-CD, Shannar A, Peter R, ...
  • Mohammadi E, Shafiee F, Shahzamani K, Ranjbar MM, Alibakhshi A, ...
  • Mutlu O, Ugurel OM, Sariyer E, Ata O, Inci TG, ...
  • Alam ARU, Islam OK, Hasan MS, Islam MR, Mahmud S, ...
  • Zeng H-L, Dichio V, Horta ER, Thorell K, Aurell E. ...
  • Angeletti S, Benvenuto D, Bianchi M, Giovanetti M, Pascarella S, ...
  • Claverie J-M. A putative role of de-mono-ADP-ribosylation of STAT۱ by ...
  • Tomaszewski T, DeVries RS, Dong M, Bhatia G, Norsworthy MD, ...
  • نمایش کامل مراجع